• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

Advertisement

Organisation › Details

Biotage AB

Biotage offers solutions, knowledge and experience in the areas of analytical and medicinal chemistry. The customers include the world's top pharma and biotech companies, as well as leading academic institutes. The company is headquartered in Uppsala, Sweden, and has offices in the United States, United Kingdom and Japan. Biotage has 245 employees and had sales of SEK 394,1m in 2009. Biotage is listed on the NASDAQ OMX Nordic Stock Exchange. *

 

	Start	2003-12-01 renamed
	Group	Biotage (Group)
	Industry	BIOTECH
	Industry 2	laboratory equipment and instruments
	Region	Uppsala
	Country	Sweden
	Street	76 Kungsgatan
	City	753 18 Uppsala
	Tel	+46-18-565900
	Fax	+46-18-591922
		Address record changed: 2008-12-07
Basic data	Employees	D: 101 to 500 (2011-01-10)
	Currency	SEK
	Annual sales	394,123,000 (sales, net, consolidated (2009) 2009-12-31)
	Profit	13,478,000 (2009-12-31)
	Cash	364,902,000 (2009-12-31)
		* Document for »About Section«: Biotage AB. (1/10/11). "Press Release: Biotage Announces New Methods for the Extraction of Key Compounds for Clinical, Environmental and Forensic Applications". Charlotte, NC.
		Record changed: 2012-02-28

More documents for Biotage (Group)

• [1] Biotage AB. (1/12/12). "Press Release: Biotage Is Subject to Extended Patent Litigation in the US"....
• [2] Biotage AB. (10/26/11). "Press Release: Interim Report January – September 2011"....
• [3] Biotage AB. (10/26/11). "Press Release: Changes in Management of Biotage AB"....
• [4] Biotage AB. (9/8/11). "Press Release: Following Biotage’s Request for Re-examination US Patent and Trademark Office Has Rejected All Claims in US Patent 7,410,571"....
• [5] Biotage AB. (8/17/11). "Press Release: Interim Report January – June 2011"....
• [6] Biotage AB. (5/9/11). "Press Release: Following Biotage’s Request for Re-examination US Patent and Trademark Office Has Rejected All Claims in US Patent 7,138,061"....
• [7] Biotage AB. (1/10/11). "Press Release: Biotage Announces New Methods for the Extraction of Key Compounds for Clinical, Environmental and Forensic Applications". Charlotte, NC....
• [8] Biotage AB. (12/16/10). "Press Release: Biotage Announces an Easy, Cost-effective Approach to the Analysis of Ethyl Glucuronide (EtG) in Urine for Clinical and Forensic Toxicology Laboratories". Uppsala....
• [9] Biotage AB. (11/30/10). "Press Release: Biotage Extends Capabilities with Addition of PEG Resins for Solid Phase Peptide Synthesis". Charlotte, NC....
• [10] Advion BioSciences, Inc.. (3/2/06). "Press Release: David Patteson Joins Advion BioSciences as President and CEO". Ithaca, NY....

To subscribe to our free, monthly [MSC] Newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

NEW: Visit our brand new forthcoming web portals Life-Sciences-Germany.com and Life-Sciences-Europe.com

» top

» Imprint  |  » Contact  |  The use of this website requires to accept the disclaimer!   |  A project of [iito] Business Intelligence © 2002-2012. Made in Germany.